跳至主要内容
临床试验/NCT05721157
NCT05721157已完成不适用

Osteoporotic Precisely Screening Using Chest Radiograph and Artificial Neural Network (OPSCAN): a Randomized Controlled Trial

National Defense Medical Center, Taiwan2 个研究点 分布在 1 个国家目标入组 4,912 人开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
4,912
试验地点
2
主要终点
newly diagnosed with osteoporosis

研究概览

简要总结

Artificial Intelligence-assisted Diagnosis and Prognostication in Osteoporosis Using Chest X-ray

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients recieved at least 1 chest X-ray examination in 2022
  • More than 66% chest X-ray identified as high risk of osteoporosis by AI-CXR

排除标准

  • Patients with history of at least 1 dual energy x-ray absorptiometry (DXA)
  • Patients with history of osteoporosis or osteoportic fracture
  • Patients recieved prescription anti-osteoporotic treatment (excluding vitamin D or calcium)
  • Patients died before 01 Jan 2023

结局指标

主要结局

newly diagnosed with osteoporosis

时间窗: Within 180 days

After performing an chest X-ray, the osteoporosis was followed.

次要结局

  • initiation of DXA examination(Within 180 days)
  • initiation of anti-osteoporotic treatment(Within 180 days)

研究者

发起方
National Defense Medical Center, Taiwan
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chin Lin

Associate Professor

National Defense Medical Center, Taiwan

研究点 (2)

Loading locations...

相似试验